Sortera Bio
PrivateLast Round
Pre Seed
May 1, 2024
Total Funding Raised
$9.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sortera Bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Pre Seed round in May 2024.
Sortera Bio is a biotechnology company that operates a biologics discovery platform to accelerate drug development through AI-powered screening technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sortera Bio Comparables
Compare Sortera Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiverse | 82% | |
| A-Alpha Bio | 81% | |
| Onava | 81% |
For institutional investors. Book with your work email.
Sortera Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sortera Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Innovation Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 84% MoM.
- Nov 26, 2024
Grew 63% QoQ from 8 to 13 employees.
For institutional investors. Book with your work email.
Sortera Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sortera Bio's valuation, stock price, and market status.
Is Sortera Bio a public or private company?
Sortera Bio is a private company.
What is the current stock price of Sortera Bio?
Sortera Bio is a private company, so its shares have no public market price. Caplight tracks Sortera Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sortera Bio worth (valuation)?
Valuation information for Sortera Bio is not publicly available.
Can I buy Sortera Bio stock?
Sortera Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sortera Bio's last funding round?
Sortera Bio's most recent funding round was Pre Seed on May 1, 2024.
Who are the main investors in Sortera Bio?
Key investors in Sortera Bio include Cambridge Innovation Capital.
Will Sortera Bio IPO soon?
No public IPO plans have been announced for Sortera Bio.
How can I track Sortera Bio secondary market activity?
Caplight tracks bids, offers, and trades in Sortera Bio's shares on secondary markets.